Structures by: Camerman A.
Total: 33
Oxcarbazepine
C15H12N2O2
Acta Crystallographica Section E (2005) 61, 5 o1313-o1315
a=5.276(2)Å b=9.307(4)Å c=24.841(7)Å
α=90.00° β=95.64(2)° γ=90.00°
Felbamate
C11H14N2O4
Acta Crystallographica Section E (2005) 61, 5 o1381-o1383
a=8.394(3)Å b=5.158(2)Å c=26.972(6)Å
α=90.00° β=101.47(2)° γ=90.00°
Methylfelbamate
C12H16N2O4
Acta Crystallographica Section E (2005) 61, 5 o1384-o1386
a=9.984(2)Å b=12.040(3)Å c=14.360(4)Å
α=96.74(2)° β=95.82(2)° γ=126.51(3)°
Nafimidone monohydrate
C15H12N2O,H2O
Acta Crystallographica Section E (2005) 61, 5 o1387-o1389
a=11.597(3)Å b=14.213(3)Å c=7.827(2)Å
α=90.00° β=90.15(2)° γ=90.00°
Nafazatrom
C16H16N2O2
Acta Crystallographica Section E (2005) 61, 6 o1544-o1545
a=28.830(5)Å b=10.896(2)Å c=8.879(2)Å
α=90.00° β=90.00° γ=90.00°
Pargyline
C11H14N,Cl
Acta Crystallographica Section E (2005) 61, 6 o1595-o1597
a=5.739(2)Å b=33.684(5)Å c=6.003(2)Å
α=90.00° β=106.79(4)° γ=90.00°
Pargyline
C11H14N,Cl
Acta Crystallographica Section E (2005) 61, 6 o1598-o1600
a=5.958(2)Å b=11.039(3)Å c=33.596(5)Å
α=90.00° β=90.00° γ=90.00°
2-(acetylamino)-N-benzyl-2-(ethylsulfinyl)acetamide
C13H18N2O3S
Acta Crystallographica Section E (2005) 61, 7 o2120-o2122
a=10.114(2)Å b=10.260(2)Å c=15.126(3)Å
α=78.70(3)° β=73.88(3)° γ=87.45(3)°
2-(Biphenyl-2-yl)-5-(1-methylhydrazino)-1,3,4-thiadiazole
C15H14N4S
Acta Crystallographica Section E (2005) 61, 7 o2164-o2166
a=13.886(3)Å b=9.898(2)Å c=10.896(2)Å
α=90.00° β=91.46(2)° γ=90.00°
2-(4-chlorobenzamido)ethanaminium chloride
C9H12Cl1N2O,Cl
Acta Crystallographica Section E (2005) 61, 7 o2283-o2285
a=6.726(2)Å b=6.837(2)Å c=25.267(5)Å
α=83.57(2)° β=83.03(2)° γ=88.03(2)°
Nafimidone hemihydrate hemihydrochloride
C30H25N4O2,Cl,H2O
Acta Crystallographica Section E (2005) 61, 6 o1532-o1533
a=9.171(3)Å b=9.428(2)Å c=16.783(2)Å
α=77.190(10)° β=75.440(10)° γ=75.110(10)°
4-imino(dimethylamino)benzenesulfonic acid
C9H12N2O3S,H2O
Acta Crystallographica Section C (1999) 55, 4 697-698
a=5.8512(2)Å b=13.0410(6)Å c=14.8412(7)Å
α=90.00° β=90.00° γ=90.00°
FF-arabino-uridine
C9H10F2N2O5
Acta Crystallographica Section C (1999) 55, 4 632-633
a=9.975(2)Å b=9.975(2)Å c=10.418(2)Å
α=90.00° β=90.00° γ=90.00°
Aziridinyl
C8H18N3OP
Acta Crystallographica Section C (1999) 55, 7 1173-1175
a=5.275(3)Å b=9.747(4)Å c=11.451(5)Å
α=96.44(3)° β=84.11(3)° γ=78.88(4)°
[(S)-(4,5-dihydro-2-phenyl-4-oxazolyl)methyl]-(S)-sulfinyloctane
C18H27NO2S
Acta Crystallographica Section C (1996) 52, 12 3207-3210
a=5.1880(10)Å b=38.076(7)Å c=9.0490(10)Å
α=90.00° β=96.320(10)° γ=90.00°
[(S)-(4,5-dihydro-2-phenyl-4-oxazolyl)methyl]-(R)-sulfinyloctane
C18H27NO2S
Acta Crystallographica Section C (1996) 52, 12 3207-3210
a=4.828(1)Å b=34.865(6)Å c=5.317(1)Å
α=90.00° β=98.93(1)° γ=90.00°
4-[(S)-(4,5-dihydro-2-phenyl-4-oxazolyl)methyl]-(S)-sulfinylphenol
C16H15NO3S
Acta Crystallographica Section C (1996) 52, 12 3207-3210
a=32.492(8)Å b=7.756(3)Å c=5.817(2)Å
α=90.00° β=90.00° γ=90.00°
C15H28NO7
C15H28NO7
Acta Crystallographica Section C (1993) 49, 2 298-300
a=9.239(4)Å b=14.475(6)Å c=6.404(3)Å
α=90° β=91.19(5)° γ=90°
Rhodamine-6g
C28H31N2O3,Cl,H2O
Acta Crystallographica Section C (2001) 57, 5 657-659
a=9.1947(13)Å b=11.240(3)Å c=13.1995(13)Å
α=95.874(13)° β=91.525(10)° γ=102.63(2)°
Rhodamine-123
C21H17N2O3,Cl,3H2O
Acta Crystallographica Section C (2001) 57, 5 657-659
a=13.5624(14)Å b=21.468(3)Å c=15.427(3)Å
α=90.00° β=95.409(12)° γ=90.00°
Ranitidine
C13H23N4O3S,Cl
Acta Crystallographica Section C (2000) 56, 8 1048-1049
a=12.1918(6)Å b=6.5318(3)Å c=22.0382(8)Å
α=90.00° β=93.985(3)° γ=90.00°
5-(biphenyl-4-yl)-2-[2-(1-methylethylidene)hydrazino]-1,3,4-thiadiazol-3-ium chloride methanol solvate
C17H17N4S,Cl,CH4O
Acta Crystallographica Section C (2005) 61, 7 o427-o430
a=7.472(3)Å b=16.437(4)Å c=15.532(2)Å
α=90.00° β=101.41(2)° γ=90.00°
1-[5-(biphenyl-2-yl)-1,3,4-thiadiazol-2-yl]methanaminium chloride
C15H14N3S,Cl
Acta Crystallographica Section C (2005) 61, 7 o427-o430
a=28.882(6)Å b=9.198(2)Å c=5.6050(10)Å
α=90.0° β=90.0° γ=90.0°
2-(Biphenyl-4-yl)-5-[2-(1-methylethylidene)hydrazino]-1,3,4-thiadiazole
C17H16N4S
Acta Crystallographica Section C (2005) 61, 7 o427-o430
a=7.988(2)Å b=14.150(3)Å c=14.545(3)Å
α=74.77(3)° β=89.60(2)° γ=80.79(2)°
7,8-Dihydroxy-4-propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolinium bromide monohydrate
C16H24NO2,Br,H2O
Acta Crystallographica Section C (2005) 61, 12 o681-o682
a=13.907(3)Å b=7.856(2)Å c=15.357(3)Å
α=90.00° β=93.21(2)° γ=90.00°
DPPE
C19H26NO,Cl
Acta Crystallographica Section C (2000) 56, 4 455-456
a=16.427(2)Å b=15.195(2)Å c=7.1940(10)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 5-isopropoxy-4-methyl-β-carboline-3-carboxylate
C18H20N2O3
Acta Crystallographica Section C (2005) 61, 4 o265-o266
a=8.5190(9)Å b=16.2110(15)Å c=11.862(2)Å
α=90.00° β=104.46(2)° γ=90.00°
4-[N-(2-Chloro-6-methylphenyl)ureido]pyridinium chloride
C13H13ClN3O,Cl
Acta Crystallographica Section C (2006) 62, 4 o190-o192
a=8.022(3)Å b=13.193(4)Å c=14.893(4)Å
α=69.06(3)° β=81.29(2)° γ=80.60(3)°
Trimetrexate
4C19H23N5O3,2C2H6OS,3H2O
Acta Crystallographica Section C (2000) 56, 10 1225-1227
a=16.124(2)Å b=16.371(2)Å c=17.7660(10)Å
α=81.676(3)° β=66.289(2)° γ=80.050(3)°
2-acetamido-N-benzyl-2-(methoxyamino)acetamide
C12H17N3O3
Acta Crystallographica Section C (2005) 61, 7 o417-o419
a=17.998(5)Å b=7.112(3)Å c=20.390(6)Å
α=90.00° β=90.00° γ=90.00°
2-acetamido-N-benzyl-2-[methoxy(methyl)amino]acetamide
C13H19N3O3
Acta Crystallographica Section C (2005) 61, 7 o417-o419
a=4.859(2)Å b=10.587(3)Å c=14.168(4)Å
α=86.84(2)° β=80.66(3)° γ=80.28(3)°
C16H13ClN2O
C16H13ClN2O
Journal of the American Chemical Society (1972) 94, 1 268-272
a=12.9284(41)Å b=13.3537(68)Å c=7.9763(17)Å
α=90° β=90.01(3)° γ=90°
C10H13N5O4
C10H13N5O4
Proceedings of the National Academy of Sciences of the United States of America (1987) 84, 23 8239-8242
a=5.711(1)Å b=11.996(2)Å c=17.664(2)Å
α=90° β=94.30(1)° γ=90°